Actinomycin D (aus Streptomyces parvulus) ≥98% (durch TLC)
Lieferant: ENZO LIFE SCIENCES AG
|
Gefahr
|
ENZOBMLGR3000005EA
99.1
CHF
ENZOBMLGR3000005
Actinomycin D (aus Streptomyces parvulus) ≥98% (durch TLC)
Actinomycin D
An intercalating transcription inhibitor and antineoplastic antibiotic. Inhibits transcription by binding to DNA at dG residues. Induces apoptosis in many cell lines, but suppresses in PC12 cells induced by topoisomrease II inhibitor etopside. Used at 5-10 µg/mL in cell culture for halting transcription. The product is not sterile.
Red-orange crystalline solid
Soluble in DMSO (>20 mg/mL), 100% ethanol (1 mg/mL) or methanol
Formel:
C₆₂H₈₆N₁₂O₁₆ MW: 1255,5 g/mol Lager Temperatur: Gefrierschrank |
MDL Number:
MFCD00005033 CAS-Nummer: 50-76-0 UN: 3462 ADR: 6.1,II |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...